Hyperliquid Rallies 11% on Trump CFTC Announcement Amid SEC Pre-IPO Push

Hyperliquid Rallies 11% on Trump CFTC Announcement Amid SEC Pre-IPO Push

HYPE rose 11% Wednesday after President Trump said the CFTC is working to bring Hyperliquid into the U.S. under federal rules. Separately, the Hyperliquid Policy Center submitted recommendations to the SEC for pre-IPO perpetual markets without share grants.

Aug 19, 2026, 08:14 PM1 min read

Written by CoinArticle’s AI Newsroom · from 2 cited sources. How we work

Trump CFTC Announcement Drives Rally

HYPE jumped 11% on Wednesday after President Trump said during a White House meeting that CFTC Chair Mike Selig is working to bring Hyperliquid into the U.S. under federal rules. The announcement provided a clear regulatory pathway for the perpetual futures platform, which has operated primarily offshore. HYPE closed the trading day near $59, building on gains from the prior two sessions.

SEC Petition on Pre-IPO Derivatives

In parallel, the Hyperliquid Policy Center and trade[XYZ] submitted recommendations to the SEC on pre-IPO perpetual markets. The proposed instruments would grant price exposure to pre-listing companies without conveying shares or investor rights, effectively allowing traders to speculate on future public valuations before official IPOs. The dual regulatory outreach—to both the CFTC for the main platform and to the SEC for new derivatives products—signals an attempt to anchor Hyperliquid across multiple federal frameworks.

Why It Matters

For Traders

U.S. regulatory clarity could reduce execution risk for HYPE positions and potentially unlock domestic venue access, though CFTC and SEC approvals remain pending.

For Investors

A domestic regulatory license would materially widen Hyperliquid's addressable market and reduce legal tail risk, a significant structural positive for the platform and its token.

For Builders

Pre-IPO perpetual instruments, if approved by the SEC, would create a new asset class on Hyperliquid's infrastructure and set a precedent for derivatives on non-listed equities.

This article is for information only and is not financial advice. Read the full disclaimer.

Related Articles

Latest News